Compositions and methods for inhibiting expression of the HAMP gene

Details for Australian Patent Application No. 2011250816 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Nakayama, Tomoko; Geick, Anke; Tan, Pamela; Lin, Herbert Y.

Agent FB Rice

Pub. Number AU-A-2011250816

Parent 2007299629

Filing date 16 November 2011

Wipo publication date 8 December 2011

International Classifications

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

1 December 2011 Complete Application Filed

8 December 2011 Application Open to Public Inspection

  Published as AU-A-2011250816

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011250817-Transmission controlling method, sender apparatus and receiver apparatus for wireless communication system

2011250815-Extendable, Retractable and Shapeable Plant Cover